Targeting mTOR pathway in gynecological malignancies: Biological rationale and systematic review of published data.

mTOR inhibitors are widely used in different malignancies with several trials testing their efficacy and safety in gynecological malignancies. We aimed to review the current evidence that support the expansion of using such drugs in the treatment of advanced gynecological cancers.